Literature DB >> 8393491

Correlation of myosin heavy chain expression in the rat with cAMP in different models of hypertension-induced cardiac hypertrophy.

I Morano1, K Adler, K Weismann, A Knorr, E Erdmann, M Böhm.   

Abstract

Both genetically determined and artificially-induced hypertension lead to cardiac hypertrophy and shift the myosin heavy chain (MHC) expression to the beta-MHC form. The cause of this change in gene expression is unknown. To contribute to the understanding of this phenomenon, we correlated the MHC expression in the left ventricle with basal, Forskolin- and isoprenaline-stimulated adenylate cyclase activity (cAMP production of membrane fractions). We used two control rat strains [Wistar-Hagemann (WH), Wistar-Kyoto (WKY)] and several rat models of hypertension: one clip-one kidney (1C-1K), desoxycorticosterone-treated rats (DOCA), rats with reduced renal mass (RRM) and spontaneously hypertensive rats (SHR). The level of hypertension correlated positively with the degree of cardiac hypertrophy (P < 0.01) and negatively (P < 0.05) with cAMP production, e.g. the higher the degree of hypertension, the lower both basal and stimulated cAMP levels. In addition we found that the lower the basal, isoprenaline- and Forskolin-stimulated cAMP production the lower was the expression of the alpha-MHC isoenzyme (P < 0.05). Thus, our data suggest that the decreased alpha-MHC expression upon hypertension-induced cardiac hypertrophy could be mediated via decreased adenylate cyclase activity and thus decreased intracellular cAMP production.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8393491     DOI: 10.1006/jmcc.1993.1045

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  1 in total

1.  Altered tension cost in (TG(mREN-2)27) rats overexpressing the mouse renin gene.

Authors:  Carsten Zobel; Persephone Zavidou-Saroti; Birgit Bölck; Klara Brixius; Hannes Reuter; Konrad Frank; Holger Diedrichs; Jochen Müller-Ehmsen; Wilhelm Bloch; Robert H G Schwinger
Journal:  Eur J Appl Physiol       Date:  2006-10-25       Impact factor: 3.078

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.